In a rat model of CCl4-induced liver fibrosis, ligustrazine alleviated hepatic injury, angiogenesis, and vascular remodelling by decreasing the level of HIF-1α (Zhang et al., 2018). Here, HIF1A is linked to Hepatic fibrosis.